Ekso Bionics Raises Capital via Series B Preferred

EKSO BIONICS ( (EKSO) ) has shared an update.

On January 20, 2026, Ekso Bionics Holdings, Inc. entered into securities purchase agreements with institutional and accredited investors for a private placement of 5,852 shares of newly designated Series B Convertible Preferred Stock, along with warrants to purchase up to 355,960 shares of common stock, which closed on January 22, 2026. The transaction, structured with conversion and exercise prices of $8.22 per share and subject to transfer, conversion, ownership caps and voting limits to prevent any single holder or the investor group from exceeding roughly 20% of the company’s voting power, is expected to yield approximately $5.3 million in net proceeds for working capital and general corporate purposes. Ekso Bionics also granted investors registration rights for the resale of the underlying common shares by mid-2026, set warrant exercisability to begin in July 2026 under specified conditions, and established detailed protective and redemption rights for the Series B preferred stock, underscoring a balance between raising growth capital and maintaining control and dilution safeguards for existing shareholders.

The most recent analyst rating on (EKSO) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on EKSO BIONICS stock, see the EKSO Stock Forecast page.

Spark’s Take on EKSO Stock

According to Spark, TipRanks’ AI Analyst, EKSO is a Neutral.

The score is held back primarily by weak financial performance (large ongoing losses and continued cash burn) and a negative-earnings valuation profile. These are partially offset by strong technical uptrend signals and some upside optionality from the proposed AI-focused business combination, though the transaction remains non-binding and uncertain.

To see Spark’s full report on EKSO stock, click here.

More about EKSO BIONICS

Ekso Bionics Holdings, Inc. operates in the medical technology sector, developing and commercializing robotic exoskeletons and related wearable devices aimed at rehabilitation, mobility, and industrial applications. The company focuses on providing solutions that enhance patient recovery and worker safety, targeting healthcare providers, rehabilitation centers, and industrial customers seeking advanced assistive technologies.

Average Trading Volume: 2,154,092

Technical Sentiment Signal: Hold

Current Market Cap: $27.89M

See more data about EKSO stock on TipRanks’ Stock Analysis page.